synjardy xr
Generic: empagliflozin, metformin hydrochloride
Labeler: boehringer ingelheim pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
synjardy xr
Generic Name
empagliflozin, metformin hydrochloride
Labeler
boehringer ingelheim pharmaceuticals, inc.
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
empagliflozin 12.5 mg/1, metformin hydrochloride 1000 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0597-0300
Product ID
0597-0300_09b6e275-e784-41d8-a75d-74a22f3e2eca
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA208658
Listing Expiration
2027-12-31
Marketing Start
2016-12-10
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05970300
Hyphenated Format
0597-0300
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
synjardy xr (source: ndc)
Generic Name
empagliflozin, metformin hydrochloride (source: ndc)
Application Number
NDA208658 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 12.5 mg/1
- 1000 mg/1
Packaging
- 1 BOTTLE in 1 CARTON (0597-0300-20) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-45)
- 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-93)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "09b6e275-e784-41d8-a75d-74a22f3e2eca", "openfda": {"nui": ["N0000187059", "N0000187058"], "unii": ["HDC1R2M35U", "786Z46389E"], "rxcui": ["1862685", "1862688", "1862691", "1862692", "1862695", "1862697", "1862700", "1862701"], "spl_set_id": ["8006ba29-ee3a-f852-a9bb-c8ec9b41cf66"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 BOTTLE in 1 CARTON (0597-0300-20) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "0597-0300-20", "marketing_start_date": "20161210"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-45)", "package_ndc": "0597-0300-45", "marketing_start_date": "20161210"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-93)", "package_ndc": "0597-0300-93", "marketing_start_date": "20161210"}], "brand_name": "Synjardy XR", "product_id": "0597-0300_09b6e275-e784-41d8-a75d-74a22f3e2eca", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Biguanide [EPC]", "Biguanides [CS]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "0597-0300", "generic_name": "empagliflozin, metformin hydrochloride", "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Synjardy", "brand_name_suffix": "XR", "active_ingredients": [{"name": "EMPAGLIFLOZIN", "strength": "12.5 mg/1"}, {"name": "METFORMIN HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "NDA208658", "marketing_category": "NDA", "marketing_start_date": "20161210", "listing_expiration_date": "20271231"}